• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷脂酰肌醇-3激酶调节亚基基因PIK3R1受雄激素直接调控,并在前列腺癌细胞中受到抑制。

The PI3K regulatory subunit gene PIK3R1 is under direct control of androgens and repressed in prostate cancer cells.

作者信息

Munkley Jennifer, Livermore Karen E, McClurg Urszula L, Kalna Gabriela, Knight Bridget, McCullagh Paul, McGrath John, Crundwell Malcolm, Leung Hing Y, Robson Craig N, Harries Lorna W, Rajan Prabhakar, Elliott David J

机构信息

Institute of Genetic Medicine, Newcastle University, Newcastle-upon-Tyne, UK.

Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, UK.

出版信息

Oncoscience. 2015 Sep 14;2(9):755-64. doi: 10.18632/oncoscience.243. eCollection 2015.

DOI:10.18632/oncoscience.243
PMID:26501081
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4606009/
Abstract

Androgen receptor (AR) signalling and the PI3K pathway mediate survival signals in prostate cancer, and have been shown to regulate each other by reciprocal negative feedback, such that inhibition of one activates the other. Understanding the reciprocal regulation of these pathways is important for disease management as tumour cells can adapt and survive when either single pathway is inhibited pharmacologically. We recently carried out genome-wide exon-specific profiling of prostate cancer cells to identify novel androgen-regulated transcriptional events. Here we interrogated this dataset for novel androgen-regulated genes associated with the PI3K pathway. We find that the PI3K regulatory subunits PIK3R1 (p85α) and PIK3R3 (p55γ) are direct targets of the AR which are rapidly repressed by androgens in LNCaP cells. Further characterisation revealed that the PIK3CA p110α catalytic subunit is also indirectly regulated by androgens at the protein level. We show that PIK3R1 mRNA is significantly under-expressed in prostate cancer (PCa) tissue, and provide data to suggest a context-dependent regulatory mechanism whereby repression of the p85α protein by the AR results in destabilisation of the PI3K p110α catalytic subunit and downstream PI3K pathway inhibition that functionally affects the properties of prostate cancer cells.

摘要

雄激素受体(AR)信号传导和PI3K通路介导前列腺癌中的生存信号,并且已显示它们通过相互负反馈相互调节,因此抑制其中一个会激活另一个。了解这些通路的相互调节对于疾病管理很重要,因为当任一单通路被药物抑制时,肿瘤细胞都可以适应并存活。我们最近对前列腺癌细胞进行了全基因组外显子特异性分析,以识别新的雄激素调节的转录事件。在此,我们针对与PI3K通路相关的新的雄激素调节基因对该数据集进行了研究。我们发现PI3K调节亚基PIK3R1(p85α)和PIK3R3(p55γ)是AR的直接靶标,在LNCaP细胞中它们会被雄激素迅速抑制。进一步的表征显示,PIK3CA p110α催化亚基在蛋白质水平上也受到雄激素的间接调节。我们表明,PIK3R1 mRNA在前列腺癌(PCa)组织中显著低表达,并提供数据表明存在一种上下文依赖性调节机制,即AR对p85α蛋白的抑制导致PI3K p110α催化亚基不稳定以及下游PI3K通路抑制,从而在功能上影响前列腺癌细胞的特性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b21/4606009/4efd82ef1b49/oncoscience-02-0755-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b21/4606009/b14dc2c81bec/oncoscience-02-0755-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b21/4606009/c117e26cb141/oncoscience-02-0755-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b21/4606009/6f663ab59ca5/oncoscience-02-0755-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b21/4606009/7b265944849e/oncoscience-02-0755-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b21/4606009/9f884615d641/oncoscience-02-0755-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b21/4606009/4efd82ef1b49/oncoscience-02-0755-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b21/4606009/b14dc2c81bec/oncoscience-02-0755-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b21/4606009/c117e26cb141/oncoscience-02-0755-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b21/4606009/6f663ab59ca5/oncoscience-02-0755-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b21/4606009/7b265944849e/oncoscience-02-0755-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b21/4606009/9f884615d641/oncoscience-02-0755-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b21/4606009/4efd82ef1b49/oncoscience-02-0755-g006.jpg

相似文献

1
The PI3K regulatory subunit gene PIK3R1 is under direct control of androgens and repressed in prostate cancer cells.磷脂酰肌醇-3激酶调节亚基基因PIK3R1受雄激素直接调控,并在前列腺癌细胞中受到抑制。
Oncoscience. 2015 Sep 14;2(9):755-64. doi: 10.18632/oncoscience.243. eCollection 2015.
2
PIK3R1 (p85α) is somatically mutated at high frequency in primary endometrial cancer.PIK3R1(p85α)在原发性子宫内膜癌中高频体细胞突变。
Cancer Res. 2011 Jun 15;71(12):4061-7. doi: 10.1158/0008-5472.CAN-11-0549. Epub 2011 Apr 8.
3
Phosphoinositide 3-OH kinase p85alpha and p110beta are essential for androgen receptor transactivation and tumor progression in prostate cancers.磷脂酰肌醇3 - 羟基激酶p85α和p110β对于前列腺癌中雄激素受体的反式激活及肿瘤进展至关重要。
Oncogene. 2008 Jul 31;27(33):4569-79. doi: 10.1038/onc.2008.91. Epub 2008 Mar 31.
4
Identification of novel androgen-regulated pathways and mRNA isoforms through genome-wide exon-specific profiling of the LNCaP transcriptome.通过对 LNCaP 转录组的全基因组外显子特异性分析鉴定新型雄激素调控途径和 mRNA 异构体。
PLoS One. 2011;6(12):e29088. doi: 10.1371/journal.pone.0029088. Epub 2011 Dec 14.
5
Androgen-regulation of the protein tyrosine phosphatase PTPRR activates ERK1/2 signalling in prostate cancer cells.雄激素对蛋白酪氨酸磷酸酶PTPRR的调节激活了前列腺癌细胞中的ERK1/2信号通路。
BMC Cancer. 2015 Jan 16;15:9. doi: 10.1186/s12885-015-1012-8.
6
PVT1 signals an androgen-dependent transcriptional repression program in prostate cancer cells and a set of the repressed genes predicts high-risk tumors.PVT1 在前列腺癌细胞中发出雄激素依赖性转录抑制程序,一组被抑制的基因可预测高危肿瘤。
Cell Commun Signal. 2021 Jan 11;19(1):5. doi: 10.1186/s12964-020-00691-x.
7
Unveiling the role of PIK3R1 in cancer: A comprehensive review of regulatory signaling and therapeutic implications.揭示PIK3R1在癌症中的作用:对调控信号传导及治疗意义的全面综述
Semin Cancer Biol. 2024 Nov;106-107:58-86. doi: 10.1016/j.semcancer.2024.08.004. Epub 2024 Aug 26.
8
PI3K-p110α mediates the oncogenic activity induced by loss of the novel tumor suppressor PI3K-p85α.PI3K-p110α 介导新型肿瘤抑制因子 PI3K-p85α 缺失诱导的致癌活性。
Proc Natl Acad Sci U S A. 2017 Jul 3;114(27):7095-7100. doi: 10.1073/pnas.1704706114. Epub 2017 Jun 19.
9
Identification of novel androgen receptor target genes in prostate cancer.前列腺癌中新型雄激素受体靶基因的鉴定
Mol Cancer. 2007 Jun 6;6:39. doi: 10.1186/1476-4598-6-39.
10
AR imposes different effects on ZFHX3 transcription depending on androgen status in prostate cancer cells.雄激素受体根据前列腺癌细胞中雄激素状态对 ZFHX3 转录产生不同影响。
J Cell Mol Med. 2022 Feb;26(3):800-812. doi: 10.1111/jcmm.17125. Epub 2021 Dec 24.

引用本文的文献

1
Cancer-Associated Genetic Aberrations and Precision Medicine.癌症相关的基因畸变与精准医学
Int J Med Sci. 2025 Jun 12;22(12):2932-2943. doi: 10.7150/ijms.109506. eCollection 2025.
2
Investigating the Potential Effects of 6PPDQ on Prostate Cancer Through Network Toxicology and Molecular Docking.通过网络毒理学和分子对接研究6PPDQ对前列腺癌的潜在影响。
Toxics. 2024 Dec 8;12(12):891. doi: 10.3390/toxics12120891.
3
An In Vitro Evaluation and Network Pharmacology Analysis of Prospective Anti-Prostate Cancer Activity from .

本文引用的文献

1
Integrative clinical genomics of advanced prostate cancer.晚期前列腺癌的整合临床基因组学
Cell. 2015 May 21;161(5):1215-1228. doi: 10.1016/j.cell.2015.05.001.
2
Androgen-regulation of the protein tyrosine phosphatase PTPRR activates ERK1/2 signalling in prostate cancer cells.雄激素对蛋白酪氨酸磷酸酶PTPRR的调节激活了前列腺癌细胞中的ERK1/2信号通路。
BMC Cancer. 2015 Jan 16;15:9. doi: 10.1186/s12885-015-1012-8.
3
Crosstalking between androgen and PI3K/AKT signaling pathways in prostate cancer cells.前列腺癌细胞中雄激素与PI3K/AKT信号通路之间的相互作用。
来自……的潜在抗前列腺癌活性的体外评估及网络药理学分析
Plants (Basel). 2023 Aug 21;12(16):3006. doi: 10.3390/plants12163006.
4
miR-92a promotes cervical cancer cell proliferation, invasion, and migration by directly targeting PIK3R1.miR-92a 通过直接靶向 PIK3R1 促进宫颈癌细胞的增殖、侵袭和迁移。
J Clin Lab Anal. 2021 Aug;35(8):e23893. doi: 10.1002/jcla.23893. Epub 2021 Jul 3.
5
New Prognostic Biomarkers in Metastatic Castration-Resistant Prostate Cancer.转移性去势抵抗性前列腺癌的新型预后生物标志物
Cells. 2021 Jan 19;10(1):193. doi: 10.3390/cells10010193.
6
Glutaminolysis is a metabolic route essential for survival and growth of prostate cancer cells and a target of 5α-dihydrotestosterone regulation.谷氨酰胺分解是前列腺癌细胞存活和生长所必需的代谢途径,也是5α-二氢睾酮调节的靶点。
Cell Oncol (Dordr). 2021 Apr;44(2):385-403. doi: 10.1007/s13402-020-00575-9. Epub 2021 Jan 19.
7
The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling.PI3K-AKT-mTOR 通路与前列腺癌:AR、MAPK 和 WNT 信号的十字路口。
Int J Mol Sci. 2020 Jun 25;21(12):4507. doi: 10.3390/ijms21124507.
8
Androgen-regulated transcription of drives alternative splicing patterns in prostate cancer.雄激素调控 基因的转录在前列腺癌中驱动了可变剪接模式。
Elife. 2019 Sep 3;8:e47678. doi: 10.7554/eLife.47678.
9
Androgen-dependent alternative mRNA isoform expression in prostate cancer cells.前列腺癌细胞中雄激素依赖的替代性mRNA异构体表达
F1000Res. 2018 Aug 3;7:1189. doi: 10.12688/f1000research.15604.1. eCollection 2018.
10
Analysis of differentially expressed genes, clinical value and biological pathways in prostate cancer.前列腺癌中差异表达基因、临床价值及生物学途径分析
Am J Transl Res. 2018 May 15;10(5):1444-1456. eCollection 2018.
J Biol Chem. 2015 Jan 30;290(5):2759-68. doi: 10.1074/jbc.M114.607846. Epub 2014 Dec 19.
4
Organoid cultures derived from patients with advanced prostate cancer.源自晚期前列腺癌患者的类器官培养物。
Cell. 2014 Sep 25;159(1):176-187. doi: 10.1016/j.cell.2014.08.016. Epub 2014 Sep 4.
5
A novel androgen-regulated isoform of the TSC2 tumour suppressor gene increases cell proliferation.一种新的雄激素调节的TSC2肿瘤抑制基因同工型可促进细胞增殖。
Oncotarget. 2014 Jan 15;5(1):131-9. doi: 10.18632/oncotarget.1405.
6
Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy.接受雄激素剥夺治疗的晚期前列腺癌的下一代测序
Eur Urol. 2014 Jul;66(1):32-9. doi: 10.1016/j.eururo.2013.08.011. Epub 2013 Aug 14.
7
Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches.雄激素剥夺治疗后的前列腺癌进展:去势抵抗的机制和新的治疗方法。
Oncogene. 2013 Dec 5;32(49):5501-11. doi: 10.1038/onc.2013.206. Epub 2013 Jun 10.
8
Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer.针对去势抵抗性前列腺癌中的 PI3K/Akt/mTOR 通路。
Endocr Relat Cancer. 2013 May 20;20(3):R83-99. doi: 10.1530/ERC-12-0394. Print 2013 Jun.
9
The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man.雄激素受体在人类去势抵抗性前列腺癌中诱导了一个独特的转录程序。
Cancer Cell. 2013 Jan 14;23(1):35-47. doi: 10.1016/j.ccr.2012.11.010. Epub 2012 Dec 20.
10
Adaptation or selection--mechanisms of castration-resistant prostate cancer.适应或选择——去势抵抗性前列腺癌的机制。
Nat Rev Urol. 2013 Feb;10(2):90-8. doi: 10.1038/nrurol.2012.237. Epub 2012 Dec 18.